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Abstract 
Background: The quality of life of prostate cancer survivors is influenced by various personal and disease-related 
factors including age and time passed from cancer diagnosis. Identification of these factors can have implications for 
improving nursing care strategies during recovery from cancer. Also, there is a lack of knowledge of health-related 
quality of life (HRQoL) among Iranian prostate cancer (PCa) survivors. 
Objective: This study aimed to describe HRQoL among Iranian PCa survivors and compare it with age at cancer 
diagnosis and time passed from it. 
Methodology: This cross-sectional study was conducted on 186 PCa survivors at the radiotherapy department of a 
large referral teaching hospital in an urban area of Iran. The demographic characteristics form, EORTC QLQ-C30, 
and EORTC QLQ - PR25 questionnaires were used to gather data. Descriptive and inferential statistics were used 
for data analysis via SPSS. 
Results: The cancer survivors with older age at cancer diagnosis had significantly lower physical (p = 0.001) and 
sexual function (p = 009), and higher social function (p = 0.03), fatigue (p = 0.02), dyspnea (p = 0.008), urinary (p = 
0.007) symptoms and financial difficulties (p = 0.03). Also, statistically significant differences between time passed 
from cancer diagnosis and physical function (p = 0.03), urinary (p = 0.001) and bowel (p = 0.02) symptoms and 
urinary aid problems (p = 0.006) were reported.  
Conclusions: Nurses need to pay more attention to age at cancer diagnosis and time passed from it among PCa 
survivors during follow-up care programs in order to improve their HRQoL.  
Keywords: Prostate cancer, health-related quality of life, nursing care, cancer survivor 
 
 
Introduction 
Prostate cancer (PCa) is the most common type of 
cancer in men across the globe (Ferlay et al., 
2015). According to a recent report, PCa with 21% 
growth in the number of new cases of cancer each 
year is the most common type of cancer in men in 
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the USA (Siegel, Miller, & Jemal, 2020). In the 
past years, the prevalence of PCa in Iran has 
increased and its current prevalence rate has been 
estimated 7-9% of all types of cancers among men 
(Pakzad et al., 2016). The 5-year survival rate of 
localized PCa in developed countries has been 
reported 98% (Howlader et al., 2015). Living for a 
longer time does not mean to have a high level of 
quality of life (QoL), because cancer treatment has 
negative impacts on patients’ QoL (Bourke et al., 
2015). Accordingly, the assessment of cancer 
outcomes not only needs the measurement of the 
cancer survival rate, but also requires the 
measurement of health-related quality of life 
(HRQoL) as the indicator of treatment outcomes in 
patients with PCa (Kikkawa et al., 2018). Most 
men undergoing treatment for PCa including 
surgery, radiotherapy and hormone therapy face 
negative treatment consequences influencing their 
HRQoL (Skolarus et al., 2012) especially at the 
first year of the treatment process (Punnen, Cowan, 
Chan, Carroll, & Cooperberg, 2015). For instance, 
surgery can have a large impact on patients’ 
erectile function and urinary continence. Also, 
radiotherapy disturbs patients’ bowel and urinary 
functions (Punnen et al., 2015). In addition, 
hormone therapy creates symptoms such as hot 
flashes, musculoskeletal and sexual dysfunctions, 
metabolic disorders, fatigue, and mood changes 
(Sountoulides & Rountos, 2013). The largest 
reductions in HRQoL often happen within early 
years after treatment, but some patients may 
experience improvements in later years (Smith et 
al., 2009; Punnen et al., 2015). Accordingly, PCa 
survivors often experience a decline in their 
HRQoL with the increase of time passed from 
cancer diagnosis (Holm et al., 2018). The 
relationship between the patients’ age at diagnosis 
and HQoL after treatment and implications for 
devising appropriate care strategies has not been 
completely explored in the international literature 
(Kurian et al., 2018). On the other hand, the 
interpretation of the findings of studies on HRQoL 
following PCa treatment is difficult, because of 
variations in patients’ age and health conditions 
(Zenger et al., 2010; Kikkawa et al., 2018). Nurses 
working in the oncology department have a crucial 
role in improving QoL among cancer survivors 
through improving their knowledge of the impact 
of cancer and relevant treatment strategies on 
patients’ lives (Nightingale et al., 2020). Also, the 
key principle for the provision of care to PCa 
survivors is to have a holistic patient-centered care 
approach in order to support them and meet their 
care needs (Ferguson & Aning, 2015). Exploratory 
studies in nursing on PCa survivors can help with 
devising appropriate nursing interventions for 
improving their QoL in the recovery period from 
cancer. However, there is no document about 
prostate cancer survivor HRQoL among Iranian 
community, which is the basis to plan for 
improving the QoL of cancer survivors. Also, it 
has been shown that Iranian nurses have a 
moderate understanding of HQoL issues in patients 
with cancer (Bahrami, 2016). Therefore, the 
present study aimed to describe HRQoL among 
Iranian PCa survivors and compare it with age at 
cancer diagnosis and time passed from it, which 
have implications for developing appropriate 
nursing care strategies for patients during recovery 
from cancer.  
Methodology 
Design and Samples: This cross-sectional 
descriptive study was conducted on PCa survivors 
in an urban area of Iran. Participants were those 
patients undergoing various treatment modalities in 
a large referral teaching hospital from April 2014 
to February 2017 and had a medical file at the 
radiotherapy department of the hospital. For 
recruitment, their medical files were retrieved and 
reviewed in terms of demographic data and cancer 
and related therapies. They were contacted via 
their phone numbers and residence addresses to be 
invited for taking part in the study. Eligibility 
criteria were: male gender, age older than 45 years, 
being diagnosed with PCa, completion of treatment 
sessions within the past 3-12 months, lack of 
metastasis to other organs, and willingness to take 
part in the study. If they had another type of cancer 
and suffered from psychiatric disorders that could 
influence their HRQoL, they were excluded. Out 
of the 285 PCa survivors who had a medical file in 
the hospital, 99 patients lacked the inclusion 
criteria or were unwilling to take part in the study. 
Therefore, 186 patients were recruited (Figure 1).  
It is noted that the adequacy of the sample size was 
confirmed given a minimum effect size of 0.15, 
power of 90% and type 1 error of 0.05 (Kim et al., 
2017) that were applied to a sampling formula. 
Although the minimum sample size was estimated 
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150 patients, all 186 patients were recruited to increase the power of our study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Process of study from sampling to data analysis 
 
Data Collection 
The demographic characteristics form: It 
included questions about the participants’ age, 
BMI (body mass index), marital status, education 
level, employment status, economic status, and 
need for help in daily living activities. It also 
contained questions about the time passed from 
cancer diagnosis, treatment modalities, 
accompanying illnesses, exercise and smoking 
habit, and history of sexual issues before PCa.  
The European Organization for Research and 
Treatment of Cancer. Quality of life 
Questionnaire-Core 30 Version 3 (EORTC QLQ-
C30 V. 3): It was used to collect data regarding 
HRQoL and was designed by the European Cancer 
Research and Treatment Agency to evaluate 
HRQoL in the past week in patients suffering from 
cancer. It consisted of 30 items under five 
functional scales of physical, role, cognitive, 
emotional, and social function, nine symptoms 
scales, and one global health-status/quality of life 
scale. Moreover, the symptoms scales included 
fatigue, nausea, pain, dyspnea, insomnia, appetite 
loss, constipation, diarrhea, and financial 
difficulties. For scoring, each item had four 
response alternatives including not at all (score 1), 
a little (score 2), quite a bit (score 3), and very 
much (score 4). The global health-status/quality of 
life scale had a response option ranging from very 
poor (score 1) to excellent (score 7) (Fayers et al., 
2015). For reliability, its Cronbach’s alpha 
coefficient for all domains was above 0.7 except 
for cognitive function domain (Ayana, Negash, 
Yusuf, Tigeneh, & Haile, 2016). Safaee et al. 
(2007) reported that the third Farsi version of 
Excluded 
(n=66) 
Age <45 (n=3); completing 
treatment before or after the past 
3-12 months (n=14); metastasis 
(n=27); other type of cancer 
(n=16); psychiatric disorder (n= 6) 
Eligible for the study 
(n =219) 
No answer to the 
invitation or 
unwillingness (n= 33) 
Data collection  
(n =186) 
Analysis (n =186) 
Analysis 
Assessed for eligibility (n=285) Enrollment 
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EORTC QLQ-C30 V. 3 was valid and reliable (r > 
0.70 for all domains). 
The European Organization for Research and 
Treatment of Cancer. Quality of Life 
Questionnaire - Prostate Cancer Module 
(EORTC QLQ - PR25): It was used as a 
supplement to the EORTC QLQ-C30 questionnaire 
for the assessment of HRQoL in patients with 
urinary tract cancer. It consisted of 25 questions in 
six domains of urinary symptoms, bowel 
symptoms, incontinence aid (those participants 
who wore an incontinence aid answered this 
question), hormonal treatment-related symptoms, 
sexual activity, and sexual function (those 
participants who had sexual activities during the 
past four weeks answered this question). Each item 
had four response alternatives: not at all (score 1), 
a little (score 2), quite a bit (score 3), and very 
much (score 4) (van Andel et al., 2008). Van Andel 
et al. (2008) confirmed its validity and reliability in 
a study in thirteen countries. It was translated to 
Farsi and was filled out by 20 PCa survivors. For 
internal consistency, the Cronbach’s alpha 
coefficients for the whole instrument and its 
domains were 0.63 and 0.85, respectively. For 
stability using the test-retest method within a two-
week interval, the Pearson correlation coefficient 
was 0.895. For both of these questionnaires, the 
domain score was calculated separately and 
converted to 0-100 based on the formula suggested 
in the questionnaires. Each domain score was 
reported separately and in the functional domains 
and symptom domains, high scores indicated a 
better condition and the severity of symptoms, 
respectively (Fayers et al., 2015). After identifying 
eligible participants, the first author (AM) met 
them at their residence and provided them with 
information about the study process. Each 
participant was provided with data collection 
questionnaires upon giving consent to take part in 
the study. 
Ethics Considerations: The research proposal was 
approved by the Ethics Committee affiliated with 
the University in which the second author (SPR) 
worked. The permission to enter the research zone 
was obtained and the participants were informed of 
the study’s purpose and method. Also, their verbal 
consent for retrieving their medical files and 
participation in the study were obtained. They were 
ensured of confidentiality of data and that they 
could leave the study at any time without any 
effect on their care. Before data collection, they 
were asked to sign the informed consent form to 
enter the study.  
Data Analysis: For data analysis, descriptive and 
inferential statistics via SPSS software v. 25 were 
used. Normal distribution of the data was evaluated 
using the Shapiro–Wilk test and the Kolmogorov–
Smirnov test. The patients’ age at cancer diagnosis 
was categorized into less than 70 years and 70 
years and/or older. The independent sample t-test 
and Chi-square test on the basis of age at diagnosis 
were used to examine the patients’ demographic 
variables. Also, for the assessment and comparison 
of HRQoL scores at two age categories, the 
independent t-test was used. In addition, time 
passed from cancer diagnosis was categorized as 
less than 1 year, 1-3 years, and 3 years and more. 
The one-way ANOVA test was used to assess and 
compare HRQoL scores across these categories. P 
value < 0.05 was regarded as a significant level.  
Results 
Demographic and Social Characteristics of the 
Patients: All participants approached, agreed to 
take part in the study. Of all, 53% (n = 99) were < 
70 years old and 47% (n = 87) aged ≥ 70 years. 
There were differences in the demographic and 
clinical characteristics of the patients in age 
groups. As such, the education level (p = 0.001), 
marital status (p = 0.01), economic status (p = 
0.001), and performing exercise (p = 0. 01) were 
significantly lower and respiratory diseases 
including asthma, bronchitis and chronic 
obstructive pulmonary diseases (COPD) (p = 0.04) 
were significantly higher in the age group of ≥ 70 
years (Table 1). 
HRQoL: the EORTC QLQ-PR25 and EORTC 
QLQ-C30 Questionnaires: Comparison of 
HRQoL scores between the age categories (age < 
70 years and ≥ 70 years) was shown in Table 2.  In 
the function domains, participants with a younger 
age at cancer diagnosis (< 70 years) had a lower 
social function (mean difference (MD) = -7.24, p = 
0.03). However, their physical function (MD = 
9.90, p = 0.001) and sexual activity (MD = 6.06, p 
= 0.009) were higher than those with a higher age 
of cancer diagnosis (≥ 70 years). In the symptoms 
domain, fatigue (MD = -6.06, p = 0.02), dyspnea 
(MD = -10.26, p = 0.008), financial difficulties 
(MD = -10.87, p = 0.03) and urinary symptoms 
(MD = -6.06, p = 0.009) were significantly lower 
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in the younger participants (p< 0.05). Comparison 
of HRQoL scores diagnosis on the basis of time 
passed from cancer indicated statistically 
significant differences in physical function (p = 
0.03).  
 
Table 1. The demographic and social characteristics of the patients 
Variable   
All 
patients 
(n=186) 
n (%) 
Age category at cancer 
diagnosis P-value 
#
 
< 70 years 
(n=99) n 
(%) 
≥ 70 year 
(n=87) n 
(%) 
Age at cancer diagnosis 
mean (±SD)  70(5.56) 65.70(3.21) 74.88(3.07) 0.001* 
Body mass index mean 
(±SD)  24.32(2.52) 
24.39 
(2.80) 24.23(2.17) 0.65* 
Marital status 
Single 49(26.3) 19 (19.2) 30 (34.5) 
0.01 Married 137(73.7) 80 (80.8   57 (67.5) 
Education level 
Illiterate 54(29) 19(19.2) 35(40.2) 
0.001 Elementary 60(32.3) 30(30.3) 30(34.5) Higher than  
elementary 72(38.7) 50(50.5) 22(25.3) 
Occupation 
Employed 44(23.7) 29(29.3) 15(17.2) 
0.11 Retired 112(60.2) 57(57.6) 55(63.2) 
Unemployed 30(16.1) 13 (13.1) 17(19.6) 
Economic status   
Sufficient 42(22.6) 28(28.3) 14(16.1) 
0.001 Relatively Sufficient 91(51.6) 56(56.6) 40(46) 
Not-sufficient 48(25.8) 15(15.2) 33(37.9) 
Need to help with daily 
living activities 
Yes 89(47.8) 46(46.5) 43(49.4) 0.68 No 97(52.2) 53(53.5) 44(50.6) 
Time passed from cancer 
diagnosis 
Less than one year 25(13.5) 11(11.1) 14(16.1) 
0.56 1-3 years 104(55.9) 58(58.6) 46 (52.9) 
More than 3 years 57(30.6) 30(30.3) 27(31) 
Treatment modality 
EBRT 67(36) 36(36.4) 31(35.6) 
0.6 
 
EBRT +RP 22(11.9) 11(11.1) 11(12.6) 
EBRT+HT 81(43.5) 41(41.4) 40(46.1) 
EBRT + RP+ HT 16(8.6) 11(11.1) 5(5.7) 
Underlying disease 
Hypertension 
Diabetes 
75(40.5) 
42(22.6) 
37(37.8) 
19(19.2) 
38(43.7) 
23(26.7) 
0.41 
0.22 
0.32 Heart disease 31(16.7) 19(19.2) 12(13.8) 
Asthma, bronchitis, 
COPD 30(16.1) 11(11.1) 19(21.8) 0.04 
Performing exercise  Some times 43(23.1) 30(30.3) 13(14.9) 0.01 Not at all 143(76.9) 69(69.7) 74(85.1) 
Smoking habit Yes 73(39.2) 35(35.4) 38(43.7) 0.24 No 113(60.8) 64(64.6) 49(56.3) 
History of sexual problem 
before cancer diagnosis 
Yes 40(21.5) 22(22.9) 18(20.7) 0.80 No 146(78.5) 77(77.8) 69(79.3) 
COPD: chronic obstructive pulmonary disease; EBRT: external beam Radiotherapy; HT: Hormone therapy; RP: 
Radical prostatectomy. # Chi-square (X2) test, * Independent sample t-test 
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Table 2. Health-related quality of life and symptoms scales by age at cancer diagnosis and 
the time passed from cancer diagnosis 
 
Age< 70 
years 
(n=99) 
Mean(SD) 
Age≥70 
year 
(n=87) 
Mean(SD) 
P 
value* 
< 1 Year 
 (n =25) 
Mean (SD) 
1-3 Year 
 (n=104) 
Mean (SD) 
> 3 Year 
 (n=57) 
Mean (SD) 
 
P-
value# 
QLQ-C30 Functioning Scale     
Global HRQOL 42.50(15.17) 40.90(14.52) 0.46 43(11.45) 43.26(15.53) 38.45(14.58) 0.13 
Physical function 68.48(13.29) 58.58(15.63) 0.001 66.93(15.21) 65.44(15.97) 59.53(13.02) 0.03 
Role function 67.50(18.50) 63.98(20.31) 0.21 66.33(18.58) 67.78(21.19) 62.57(15.83) 0.26 
Emotional 
function 64.56(16.16) 64.08(15.78) 0.83 66(18.14) 65.30(16.42) 61.84(13.90) 0.36 
Cognitive 
function 77.77(20.48) 74.71(18.47) 0.28 72.66(21.98) 77.40(19.83) 76.02(18.09) 0.55 
Social function 53.87(23.78) 61.11(22.39) 0.03 62(22.83) 56.57(23.95) 56.43(22.65) 0.55 
QLQ-C30 Symptom Scale     
Fatigue  30.97(16.51) 37.03(20.09) 0.02 32(19.59) 32.69(19.38) 36.64(16.12) 0.37 
Nausea  9.42(12.17) 10.53(12.98) 0.54 11.33(15) 8.65(11.37) 11.69(13.35) 0.28 
Pain  26.09(18.77) 28.35(20.66) 0.43 27.33(17.92) 25.48(19) 30.11(21.46) 0.36 
Dyspnea 21.54(23.48) 31.80(23.79) 0.008 22.66(24.94) 28.84(27.10) 23.39(24.36) 0.33 
Insomnia  35.01(26.67) 31.41(26.09) 0.35 28(26.66) 33.97(26.26) 34.50(26.70) 0.55 
Appetite  24.24(26) 30.26(27.67) 0.12 34.66(32.60) 24.67(26.68) 28.07(24.22) 0.23 
Constipation  26.62(27.72) 31.41(25.59) 0.65 20(23.57) 32.69(26.26) 30.99(28.07) 0.1 
Diarrhea  22.89(25.92) 21.45(27.83) 0.71 18.66(25.60) 22.11(27.32) 23.97(26.54) 0.71 
Financial  45.45(33.14) 56.32(35.33) 0.03 56(32.94) 48.07(34.70) 52.63(35.04) 0.5 
QLQ-PR25 Scale     
Sexual activity 21.38(17.01) 15.32(13.97) 0.009 16(31.15) 17.14(15.48) 22.22(17.34) 0.1 
Sexual  function 
(conditional) a 
51.66(10.24) 
 (n=10) 
41.62(13.60) 
 (n=4) 0.15 
41.66(23.56) 
(n= 2) 
51.04(11.30) 
(n=8) 
47.87(8.02) 
(n=4) 0.62 
Urinary 
symptoms 25.84(12.89) 31.13(13.49) 0.007 19.16(7.97) 28.16(13.09) 32.60(13.95) 0.001 
Bowel symptoms 10.35(8.59) 9.77(8.63) 0.64 8.33(8.33) 9.13(8.17) 12.57(9.06) 0.02 
Hormonal 
symptoms 13.24(9.07) 15.83(10.42) 0.07 10.66(6.39) 14.63(10.61) 15.78(9.14) 0.08 
Urinary aid 
problems 
(conditional) b 
85.33(19.43) 
 (n=25) 
77.38(22.32) 
 (n=28) 0.17 
44.44(19.24) 
(n=3) 
82.05(16.94) 
(n=26) 
84.72(21.93) 
(n=24) 0.006 
HRQoL: Health-Related Quality of Life; QLQ-C30: Quality of life Questionnaire-Core 30; QLQ-PR25: Quality of Life 
Questionnaire - Prostate Cancer Module   a This section was related to questions 25-22, and only those patients who had sexual 
activities in the past 4 weeks responded to these questions. 
b
 This section was related to the difficulty of using incontinence aid, and they answered this question only if wore an incontinence 
aid.  * Independent t-test  # One-way ANOVA 
 
 
 
The post hoc test showed a statistically significant 
difference between those participants with 1-3 
years passed from cancer diagnosis and those 
patients with > 3 years passed from cancer 
diagnosis (MD = 5.91, p = 0.04). For urinary 
symptoms (p = 0.001), those participants with < 1  
 
 
 
year passed from cancer diagnosis had statistically 
significant differences with those participants with 
1-3 years and > 3 years passed from cancer 
diagnosis (MD = -8.99, p = 0.005; MD = -13.43, p 
= 0.001, respectively). Regarding bowel symptoms 
(p = 0.02), a statistically significant difference was 
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reported between those participants with 1-3 years 
passed from cancer diagnosis and those 
participants with > 3 years passed from cancer 
diagnosis (MD = -3.43, p = 0.03). For urinary aid 
problems (p = 0.006), the participants with < 1 
year passed from cancer diagnosis had statistically 
significant differences with these participants with 
1-3 years passed from cancer diagnosis (MD = -
37.60, p = 0.007) and those participants with > 3 
years passed from cancer diagnosis (MD = -40.27, 
p = 0.004)). There were no statistically significant 
differences in other functions and symptom scales 
on the basis of time passed from cancer diagnosis 
(p> 0.05) (Table 2). 
Discussion 
This study described HRQoL among Iranian PCa 
survivors and compared it with age at diagnosis 
and time passed from it. We found that those PCa 
survivors with older age at cancer diagnosis had 
lower physical and sexual function, and higher 
fatigue, dyspnea, urinary symptoms and financial 
difficulties. Also, there was a statistically 
significant difference between time passed from 
cancer diagnosis and physical function, urinary and 
bowel symptoms and urinary aid problems.   
In this study, the participants with older age at 
cancer diagnosis reported lower physical function 
and sexual activity. Age is the most important 
factor influencing HRQoL in patients with PCa 
(Porreca et al., 2018). Similar to our study 
findings, Kurian et al. (2018) showed that patients 
with PCa and at a younger age at diagnosis had 
better physical function and sexual activity than 
those with an older age (> 70 years) at PCa 
diagnosis. Nevertheless, the interpretation of our 
finding indicating the relationship between the 
increase of age and reduction of HRQoL should be 
done with caution, because similar changes may be 
observed due to the aging process. For example, 
the study by Pinkawa et al. (2009) on HRQoL in 
patients with PCa before treatment showed that the 
patient’s age had a major impact on HRQoL before 
the start of the first treatment process. Therefore, 
decreased sexual activity related to age should be 
considered during the interpretation of our 
findings. Moreover, in this study, those PCa 
survivors with a younger age at diagnosis had a 
statistically significant difference in the exercise 
performance. It is believed that younger age at 
diagnosis can have a positive effect on patients’ 
physical function and sexual activity (Galvão et al., 
2014; Cormie et al., 2015). Also, the study finding 
showed that survivors with more than three years 
passed from cancer diagnosis had significantly 
lower physical activity. In this line, Smith et al. 
(2009) documented that physical performance 
reduced with increasing the time passed from the 
diagnosis of PCa. Therefore, oncology nurses can 
include physical activity programs to routine 
follow up care, particularly for those PCa survivors 
with an older age (Mishra et al., 2014; Mardani et 
al., 2020). 
In the present study, fatigue was reported to be 
higher in those patients with an older age at cancer 
diagnosis. Giacalone et al. (2013) reported that 
fatigue in patients with cancer increased with age. 
Also, Kurian et al. (2018) indicated that fatigue 
associated with age was higher in survivors with a 
higher age at cancer diagnosis. Fatigue as one of 
the most important symptoms influencing the QoL 
of PCa survivors especially older patients can be 
relieved by nurses through regular physical 
activities (Tomlinson et al., 2014), 
psychoeducational support and nutritional 
counseling (Berger et al., 2015). 
Also, the study finding revealed that dyspnea was 
higher in the participants with older age at cancer 
diagnosis. Van de Poll-Franse et al. (2011) 
examined HRQoL in ordinary people using the 
EORTC QLQ-C30 questionnaire and showed that 
dyspnea similar to most EORTC QoL symptoms 
increased with age. Also, it has been shown that 
dyspnea in cancer patients is associated with the 
history of respiratory conditions such as smoking, 
asthma and COPD (McKenzie et al., 2018). In 
addition, Damani et al. (2018) reported that 
dyspnea in cancer patients was associated with 
fatigue. Given the significance of fatigue and 
dyspnea as well as the history of respiratory 
illnesses in older survivors of PCa in the current 
study, our study findings was consistent with those 
of studies reviewed above. Due to the chronic 
nature of dyspnea in PCa survivors, nurses can 
educate patients and their family caregivers about 
how to follow healthy lifestyles, use psycho-
emotional support, manage anxiety, and learn 
relaxing and visualization exercises as a self-
management strategy to mitigate dyspnea (Ramos 
et al., 2017). 
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This study showed that financial difficulties were 
influenced by age at cancer diagnosis. It is 
believed that cancer can impose economic and 
financial burdens on its survivors (Sharp, Carsin, 
& Timmons, 2013). Sharp and Timmons (2016) 
reported that 48% of patients with prostate and 
breast cancers experienced economic stress. An 
Iranian study showed that PCa imposed a 
considerable financial burden on the Iranian 
healthcare system and patients (Mojahedian et al., 
2019). Also, Zenger et al. (2010) and Sharp et al. 
(2013) indicated that financial difficulties in 
patients with PCa were inversely correlated with 
their age, which was not consistent with the results 
of the current study. The occupation and economic 
status of the participants in this study justifies the 
financial difficulties experienced by older 
survivors. On the other hand, Sharp and Timmons 
(2016) found a relationship between economic 
burdens and HRQoL associated with cancer, which 
could be attributed to a reduction in most aspects 
of QoL in older cancer survivors. Better 
understanding of financial difficulties faced by 
PCa survivors can help nurses find appropriate 
referral and economic healthcare services (Osawa 
et al., 2016). 
In this study, the participants with more than 3 
years passed from cancer diagnosis reported more 
bowel problems. Similarly, Smith et al. (2009) 
reported that patients with PCa who were treated 
using radiotherapy with or without hormone 
therapy experienced more bowel problems after 
three years of diagnosis. Previous research has less 
focused on how to manage bowel problems 
including rectal bleeding in PCa survivors from the 
nursing perspective. However, lifestyle changes 
including the increase of physical activity, 
reduction of weight and the body mass index, and 
quitting smoke can alleviate bowel problems in 
PCa survivors undergoing pelvic radiation 
(Thomas et al., 2013). 
The present study showed that urinary symptoms 
were more common in the participants with older 
age at diagnosis and also were higher in those 
participants with longer time passed from cancer 
diagnosis. Similarly, Porreca et al. (2018) found 
that patients with an older age who were newly 
diagnosed with PCa suffered more from urinary 
problems. In addition, it has been shown that 
urinary symptoms and urinary incontinence are 
associated with age and are lower in PCa patients 
diagnosed at a younger age (Pinkawa et al., 2009). 
Also, patients with PCa experience more urinary 
problems in all treatment groups even after three 
years (Smith et al., 2009). From the nursing 
perspective, the efficacy of pelvic floor muscle 
training in combination with biofeedback has been 
shown effective for the management of urinary 
issues in PCa (K. Kim & Kim, 2017; Mardani et 
al., 2020), that can be incorporated into nursing 
care for improving their QoL.  
In the present study, only 7.5% of the participants 
who were within 3-12 months after treatment 
reported having sexual intercourse in the past four 
weeks indicating the effect of cancer treatment on 
the sexual dysfunction. Also, those patients with an 
older age had lower sexual activities and sexual 
function. Treatment for PCa including 
radiotherapy, prostatectomy, and hormone therapy 
has a significant effect on the sexual function of 
patients with PCa and its survivors (Zelefsky et al., 
2014; Canalichio, Jaber, & Wang, 2015). Cormie 
et al. (2015) reported that 27% of PCa survivors in 
initial hormonal therapy had sexual intercourse in 
the past four weeks during initial hormone therapy 
based on the results of the QLQ-PR25 
questionnaire. Another study showed that about 
36% of patients with PCa undergoing radiotherapy 
were sexually active during the past two weeks 
(van den Bergh et al., 2012). Kikkawa et al. (2018) 
also reported a low sexual function in older 
patients with PCa. As shown in previous research, 
sexual intercourse has an association with the QoL 
of PCa survivors and is emphasized in the sexual 
rehabilitation of these patients (Kim & Kim, 2017). 
Nurses can educate patients about sexual 
dysfunction due to the treatment process and how 
they can relieve it through regular physical 
activity, diet therapy, pelvic floor exercises, and 
relaxation (Huri, Akel, & Şahin, 2016; Mardani et 
al., 2020). 
The mean scores of HRQoL in most dimensions in 
the PCa survivors was lower than those of other 
studies in different countries in this study, but no 
studies in the international literature were available 
to be used for the comparison of findings. 
Strengths and Limitations: This was the first 
study on PCa survivors in the Iranian cultural 
context. Studies with larger sample sizes in 
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multicenter are needed to improve our 
understandings of the study concept and help with 
the generalizability of our findings. There was a 
lack of access to the Gleason scores as a strong 
predictor of outcome for men diagnosed with 
prostate carcinoma (Pierorazio et al., 2013) and 
clinical stage of PCa in the participants’ medical 
files to assess the disease risk in patients (Mapelli 
& Picchio, 2015), that should be considered in 
future studies. Also, older age is generally 
associated with low HRQoL. However it was 
impossible to assess HRQoL associated with age 
and compare it with that in the participants in the 
younger age group. In addition, the cross-sectional 
design of this study hindered a longitudinal 
assessment of HRQoL among PCa. 
Conclusion and Implication for practice: With a 
growing number of PCa survivors, it is important 
to monitor HRQL in patients after treatment. In 
this study, HRQoL in the PCa survivors was 
influenced by the patients’ age at diagnosis and 
time passed from cancer diagnosis. This study 
highlights the importance of paying attentions to 
disease-related symptoms such as fatigue, and 
dyspnea, financial difficulties, urinary symptoms 
in such patients. Nurses need to recognize the 
extent of side effects of treatment modalities 
experienced by cancer survivors. PCa survivors 
have significant information needs about HRQoL 
after treatment and nurses are well-placed to 
provide appropriate care in term of the provision of 
information and supportive care to them for 
improving their HRQoL. In addition, the findings 
of this study can provide knowledge regarding 
symptoms and consequences of treatment in PCa 
survivors with the consideration of age at diagnosis 
and time passed from cancer diagnosis. Also, our 
findings call for the integration of the science of 
geriatric oncology into clinical practice and health 
sciences to meet older patients’ needs similar to 
younger patients.  
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